AgingResearch.NewsJoin free

Phase 1Not yet recruiting

Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert

An Open-Label, Four-Treatment, Parallel Study of the Comparative Pharmacokinetics of a Progesterone Intravaginal Ring (IVR) 8 mg and 12 mg/Day Versus Progesterone Vaginal Insert 100mg

Sponsor
Daré Bioscience, Inc. (Industry)
Enrolment
60 planned
Conditions
Pre Term Birth
Interventions
Progesterone
Ages
adults, older adults
Registry
NCT06668896

Full record on ClinicalTrials.gov

From the registry

This study is looking for healthy female adults to use an vaginal ring with differing amounts of the hormone progesterone and go through a series of blood draws to measure how much progesterone is in the body following the use of these vaginal rings over an extended period of time.

Primary outcomes

  • Systemic pharmacokinetics of progesterone, Concentration over 24 hours

History

  1. Study completion expected

  2. Primary completion expected

  3. Started

  4. Last registry update

  5. Registered